Cornerstone Capital Management Holdings LLC. lowered its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 0.3% during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 39,899 shares of the medical instruments supplier’s stock after selling 123 shares during the quarter. Cornerstone Capital Management Holdings LLC.’s holdings in DENTSPLY SIRONA were worth $2,586,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also recently bought and sold shares of XRAY. BlackRock Inc. increased its stake in shares of DENTSPLY SIRONA by 3,103.7% during the 1st quarter. BlackRock Inc. now owns 13,891,329 shares of the medical instruments supplier’s stock worth $867,376,000 after purchasing an additional 13,457,730 shares during the last quarter. Clearbridge Investments LLC increased its stake in shares of DENTSPLY SIRONA by 34.6% during the 1st quarter. Clearbridge Investments LLC now owns 5,258,060 shares of the medical instruments supplier’s stock worth $328,313,000 after purchasing an additional 1,353,040 shares during the last quarter. Principal Financial Group Inc. increased its stake in shares of DENTSPLY SIRONA by 22.3% during the 2nd quarter. Principal Financial Group Inc. now owns 6,474,432 shares of the medical instruments supplier’s stock worth $419,802,000 after purchasing an additional 1,181,547 shares during the last quarter. Point72 Asset Management L.P. purchased a new stake in shares of DENTSPLY SIRONA during the 1st quarter worth approximately $64,184,000. Finally, Renaissance Technologies LLC increased its stake in shares of DENTSPLY SIRONA by 246.0% during the 1st quarter. Renaissance Technologies LLC now owns 1,044,558 shares of the medical instruments supplier’s stock worth $65,222,000 after purchasing an additional 742,700 shares during the last quarter. 93.87% of the stock is currently owned by hedge funds and other institutional investors.

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) opened at 59.50 on Wednesday. The company’s market capitalization is $13.66 billion. The stock’s 50 day moving average is $57.94 and its 200 day moving average is $61.07. DENTSPLY SIRONA Inc. has a 52 week low of $52.54 and a 52 week high of $65.68.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its earnings results on Wednesday, August 9th. The medical instruments supplier reported $0.65 earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.65. The firm had revenue of $992.70 million during the quarter, compared to analyst estimates of $1 billion. DENTSPLY SIRONA had a negative net margin of 20.57% and a positive return on equity of 7.24%. The business’s revenue was down 2.9% on a year-over-year basis. During the same quarter last year, the business earned $0.76 EPS. On average, equities research analysts expect that DENTSPLY SIRONA Inc. will post $2.68 earnings per share for the current year.

COPYRIGHT VIOLATION NOTICE: “DENTSPLY SIRONA Inc. (XRAY) Holdings Lowered by Cornerstone Capital Management Holdings LLC.” was originally posted by Watch List News and is the property of of Watch List News. If you are reading this report on another domain, it was copied illegally and republished in violation of US and international copyright & trademark legislation. The legal version of this report can be accessed at https://www.watchlistnews.com/dentsply-sirona-inc-xray-holdings-lowered-by-cornerstone-capital-management-holdings-llc/1638842.html.

XRAY has been the subject of several research analyst reports. BidaskClub upgraded shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research note on Friday, June 30th. HC Wainwright initiated coverage on shares of DENTSPLY SIRONA in a research note on Tuesday, July 11th. They set a “buy” rating and a $74.00 price target for the company. Credit Suisse Group restated an “outperform” rating and set a $75.00 price target (up previously from $67.00) on shares of DENTSPLY SIRONA in a research note on Thursday, July 13th. Zacks Investment Research upgraded shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating and set a $72.00 price target for the company in a research note on Thursday, July 13th. Finally, Stifel Nicolaus restated a “buy” rating and set a $66.00 price target (down previously from $70.00) on shares of DENTSPLY SIRONA in a research note on Thursday, August 10th. Two equities research analysts have rated the stock with a sell rating, four have given a hold rating and five have assigned a buy rating to the company. The stock currently has a consensus rating of “Hold” and an average target price of $65.89.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.